Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maxwell Therapeutics
Vancouver, British Columbia, Canadarwavetech.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Maxwell Therapeutics, incubated at the University of British Columbia, develops regenerative biotechnology aimed at restoring multiple interdependent layers of the retina. The company has focused on high-throughput devices to accelerate research timelines in treating degenerative or traumatic eye conditions. No clinical results are available as programs appear preclinical.
- Therapeutic areas
- Ophthalmology
- Modalities
- Cell therapyBiomaterials
- Industry
- Biotech
02
Partnerships
University of British Columbia/incubation partnership
Beyond the preview
Go deeper on Maxwell Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maxwell Therapeutics.